Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Using Urine Samples to Identify Lung Cancer

Memorial Sloan Kettering Cancer Center · with EARLY Labs · NCT06033248

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–90 · All sexes
Healthy volunteers
Accepted
Study type
Observational
Target enrollment
210
US sites recruiting
7
Study start
August 24, 2023
Record last updated
September 15, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The researchers are doing this study to test the ability of an animal biosensor platform (ABP) to detect NSCLC. Participants in this study will either be diagnosed with NSCLC, suspected to have NSCLC, or have not been diagnosed or suspected to have NSCLC.

The ABP test uses laboratory animals that are trained to detect (by smell) different chemicals in urine. Studies show that people with lung cancer have unique chemicals in their urine that are not present in people without lung cancer, and researchers think these chemicals can be used to identify people with lung cancer without the need for invasive procedures (like biopsy).

Being studied: urine sample

Conditions: Non Small Cell Lung Cancer

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Phase I (with NSCLC): Aged 18 to 90 years with histologically proven, previously untreated stage I, II, or IIIA NSCLC

°Note: Single, monolateral nodule of at least 50% solid composition visible on a Chest CT scan that is suspicious for a primary neoplasm as confirmed by an official MSK radiologist read

  • Phase I (without NSCLC): Aged 18 to 90 years with patient confirmed absence of NSCLC
  • Phase II: Aged 18 to 90 years with suspected but undiagnosed stage I, II, or IIIA NSCLC by CT and/or PET scan criteria

Exclusion Criteria

  • Aged \<18 years
  • Lack of available results from low-dose CT
  • Receipt of radiation, chemotherapy, biological therapy, resection, or any other treatment for any cancer in the previous year
  • Pregnant (for women)
  • Taking drugs that affect the immune system
  • Chronic disease related to the immune system
  • Missing clinical data (i.e., current clinical staging)

Recruiting US locations

  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities)

    Basking Ridge, NJ 07920

    Site contact: Gaetano Rocco, MD · 212-639-3478

  • Memorial Sloan Kettering Monmouth (All Protocol Activities)

    Middletown, NJ 07748

    Site contact: Gaetano Rocco, MD · 212-639-3478

  • Memorial Sloan Kettering Bergen (All Protocol Activities)

    Montvale, NJ 07645

    Site contact: Gaetano Rocco, MD · 212-639-3478

  • Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities)

    Commack, NY 11725

    Site contact: Gaetano Rocco, MD · 212-639-3478

  • Memorial Sloan Kettering Westchester (All Protocol Activities)

    Harrison, NY 10604

    Site contact: Gaetano Rocco, MD · 212-639-3478

  • Memorial Sloan Kettering Cancer Center (All Protocol Activities)

    New York, NY 10065

    Site contact: Gaetano Rocco, MD · 212-639-3478

  • Memorial Sloan Kettering Nassau (All Protocol Activities)

    Uniondale, NY 11553

    Site contact: Gaetano Rocco, MD · 212-639-3478

Study contacts (from the official record)

  • Gaetano Rocco, MD · 212-639-3478 · roccog@mskcc.org
  • David Jones, MD · 212-639-6428
All healthy volunteers studies in New Jersey →
Using Urine Samples to Identify Lung Cancer (NCT06033248) | Bored Studies